4//SEC Filing
Faulkner Robert C. 4
Accession 0001104659-23-081725
CIK 0001769804other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 6:50 PM ET
Size
7.0 KB
Accession
0001104659-23-081725
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Faulkner Robert C.
Director
Transactions
- Award
Common Stock
2023-07-13+21,598→ 21,598 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The reported securities will vest in full on the one-year anniversary of the grant date, subject to Mr. Faulkner's continued service on the Issuer's board through the vesting date or the earlier occurrence of a "corporate transaction" (as defined in the Issuer's 2020 Equity Incentive Plan). As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.
- [F2]The securities were granted to Mr. Faulkner in connection with his service as a member of the Board of Directors of the Issuer. Mr. Faulkner, a managing director of Redmile Group, LLC ("Redmile"), was elected to the board of the Issuer as a representative of Redmile and its affiliates. Pursuant to the policies of Redmile, Mr. Faulkner holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]Mr. Faulkner was elected to the board of directors of the Issuer as a representative of Redmile and its affiliates. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
Related Parties
1- filerCIK 0001831991
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 6:50 PM ET
- Size
- 7.0 KB